Kalshi runs a real-money market on this question. Norynta mirrors it with play credits: it opened at the Kalshi price and settles exactly as that market does. Players and a labelled market tracker move the price from there. Think the crowd is wrong? Trade against it.
If federal legislation requiring AI biosecurity controls has become law after Issuance and before Jul 1, 2027, then the market resolves to Yes. A qualifying federal law must require evaluations or safeguards for AI models or systems that specifically address biological misuse or harm. Mandatory biosecurity testing or evaluations qualify, as do controls on access, capabilities, security, deployment, or procurement tied to biological risk. The requirement may be part of a broader AI law or apply only to a defined sector or federal procurement. Studies, voluntary standards, funding, and gene-synthesis, laboratory, or biological-data rules without an operative AI-model or system requirement do not qualify. General AI or cybersecurity requirements and incident reporting alone are insufficient without the defined biosecurity evaluation or safeguard. A later effective date does not delay qualification. An example of this is Section 1654 of S. 4784, the Senate FY2027 defense authorization bill. Resolution: this play-money market resolves to the same result as the official Kalshi market settlement, linked as this market's resolution source. Observation time: the source market's final settlement after trading closes at 2027-07-01T03:59:00Z (UTC). If the source market is voided, cancelled, or its result is unavailable or ambiguous, this market is voided and positions are refunded.
Forecasts and play credits have no cash value. At resolution each winning share pays 1 play credit and your calibration record updates.